The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
155 jobs Number of planned job creations
Announcement Date
22 March 2006
Employment effect (start)
1 January 2007
Foreseen end date
Description
Abbott Laboratories yesterday announced plans for a 36 million investment in Donegal, creating 155 jobs. The US group, which already operates six plants in the Republic of Ireland, said it would acquire the Donegal town plant of Hospira Ireland, originally part of the Abbott group. Abbott's diabetes care division will manufacture test strips for use in the company's blood glucose monitoring systems.
The US-owned Abbott group spun off its hospital products division into a separate publicly-listed company, Hospira, in April 2004. In August 2005 last, Hospira announced it was closing its medical goods factory in Donegal, with the 560 jobs there being phased out by the end of 2006. Many of the new jobs are likely to be filled by laid-off by Hospira workers. Abbott said it expected to begin production in Donegal in 2007. Recruitment will start in the second half of this year with the 155-job target being achieved over several years.
Abbott employs more than 2,200 people in Ireland, making it one of the country's most significant multinational employers and making the Republic one of its largest overseas locations.
Sources
20 March 2023: The Irish Times
Citation
Eurofound (2006), Abbott, Business expansion in Ireland, factsheet number 63178, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/63178.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...